BDRX · Biodexa Pharmaceuticals
The AI's read
The story gives no new detail about Biodexa's sales, products, finances, or research. The share move reflects trading, not a reported change to the business, so it does not change how the company looks.
Biodexa Pharmaceuticals shares rose 13.3% to $0.55 after hours, but the report gives no company news, so the business view is unchanged.
The story gives no new detail about Biodexa's sales, products, finances, or research. The share move reflects trading, not a reported change to the business, so it does not change how the company looks.
Impact BioMedical shares rose 10.77% to $3.77 after hours, but the report gives no company news, so the business view is unchanged.
Akari Therapeutics shares rose 9.64% to $7.96 after hours, but the report gives no company news, so the business view is unchanged.
Acrivon Therapeutics shares rose 8.66% to $1.87 after hours, but the report gives no company news, so the business view is unchanged.
Healthcare Triangle shares rose 8.53% to $0.41 after hours, but the report gives no company news, so the business view is unchanged.
IGC Pharma shares rose 8.37% to $0.27 after hours, but the report gives no company news, so the business view is unchanged.
Follow Biodexa Pharmaceuticals (BDRX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BDRX